{"id":"https://openalex.org/W2494508339","doi":null,"title":"The Role of the Dynorphin/Kappa-opioid Receptor System and CREB in the Compulsive Behaviors Associated with Extended Access to Methamphetamine /","display_name":"The Role of the Dynorphin/Kappa-opioid Receptor System and CREB in the Compulsive Behaviors Associated with Extended Access to Methamphetamine /","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2494508339","mag":"2494508339"},"language":"en","primary_location":{"id":"pmh:oai:escholarship.org/ark:/13030/qt38q9k9zq","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/38q9k9zq","pdf_url":"https://escholarship.org/uc/item/38q9k9zq","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"etd"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://escholarship.org/uc/item/38q9k9zq","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039615031","display_name":"Jessie Margolis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jessie Margolis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5039615031"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6478999853134155,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6478999853134155,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.3402999937534332,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dynorphin","display_name":"dynorphin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/kappa-opioid-receptor","display_name":"kappa opioid receptor","score":0.9589999914169312},{"id":"https://openalex.org/keywords/creb","display_name":"CREB","score":0.9819999933242798},{"id":"https://openalex.org/keywords/methamphetamine","display_name":"methamphetamine","score":0.6819999814033508},{"id":"https://openalex.org/keywords/compulsive-drug-taking","display_name":"compulsive drug taking","score":0.7549999952316284},{"id":"https://openalex.org/keywords/stimulant-dependence","display_name":"stimulant use disorder","score":0.7710000276565552},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.8230000138282776},{"id":"https://openalex.org/keywords/mesolimbic-pathway","display_name":"mesolimbic system","score":0.796999990940094},{"id":"https://openalex.org/keywords/addiction-treatment-targets","display_name":"addiction treatment targets","score":0.47999998927116394}],"concepts":[{"id":"https://openalex.org/C151077648","wikidata":"https://www.wikidata.org/wiki/Q324076","display_name":"Dynorphin","level":5,"score":0.9414567947387695},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.8537112474441528},{"id":"https://openalex.org/C1629964","wikidata":"https://www.wikidata.org/wiki/Q106950729","display_name":"CREB","level":4,"score":0.8302550315856934},{"id":"https://openalex.org/C2780376393","wikidata":"https://www.wikidata.org/wiki/Q191924","display_name":"Methamphetamine","level":2,"score":0.7195608615875244},{"id":"https://openalex.org/C184389661","wikidata":"https://www.wikidata.org/wiki/Q14897645","display_name":"\u03ba-opioid receptor","level":4,"score":0.6012058258056641},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.502021312713623},{"id":"https://openalex.org/C2777650357","wikidata":"https://www.wikidata.org/wiki/Q1569460","display_name":"Mesolimbic pathway","level":5,"score":0.4511205852031708},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.43962305784225464},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.41832396388053894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4097678065299988},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3633134961128235},{"id":"https://openalex.org/C88016717","wikidata":"https://www.wikidata.org/wiki/Q417189","display_name":"Opioid peptide","level":4,"score":0.2921704947948456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2819852828979492},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25329169631004333},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2290463149547577},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18303906917572021},{"id":"https://openalex.org/C2780948874","wikidata":"https://www.wikidata.org/wiki/Q640562","display_name":"Ventral tegmental area","level":4,"score":0.16778290271759033},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.10261803865432739},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.05729168653488159},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:escholarship.org/ark:/13030/qt38q9k9zq","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/38q9k9zq","pdf_url":"https://escholarship.org/uc/item/38q9k9zq","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"etd"},{"id":"pmh:qt38q9k9zq","doi":null,"is_oa":true,"landing_page_url":"http://www.escholarship.org/uc/item/38q9k9zq","pdf_url":"http://www.escholarship.org/uc/item/38q9k9zq","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Margolis, Jessie. (2014). The Role of the Dynorphin/Kappa-opioid Receptor System and CREB in the Compulsive Behaviors Associated with Extended Access to Methamphetamine /. UC San Diego: Biology. Retrieved from: http://www.escholarship.org/uc/item/38q9k9zq","raw_type":"dissertation"},{"id":"mag:2494508339","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/content/qt38q9k9zq/qt38q9k9zq.pdf?t=o94ahj","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:escholarship.org/ark:/13030/qt38q9k9zq","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/38q9k9zq","pdf_url":"https://escholarship.org/uc/item/38q9k9zq","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"etd"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2494508339.pdf","grobid_xml":"https://content.openalex.org/works/W2494508339.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W1560942118","https://openalex.org/W1671833268","https://openalex.org/W1832429552","https://openalex.org/W1965435203","https://openalex.org/W1966868706","https://openalex.org/W1967332436","https://openalex.org/W1968120534","https://openalex.org/W1979031324","https://openalex.org/W1980492003","https://openalex.org/W1983348906","https://openalex.org/W1984203909","https://openalex.org/W1986400882","https://openalex.org/W2008264529","https://openalex.org/W2010370084","https://openalex.org/W2010531200","https://openalex.org/W2012213517","https://openalex.org/W2014459415","https://openalex.org/W2018312069","https://openalex.org/W2031307224","https://openalex.org/W2034928212","https://openalex.org/W2038246573","https://openalex.org/W2050279789","https://openalex.org/W2055207238","https://openalex.org/W2062106032","https://openalex.org/W2064164996","https://openalex.org/W2068213268","https://openalex.org/W2079086643","https://openalex.org/W2080481456","https://openalex.org/W2084434011","https://openalex.org/W2085019729","https://openalex.org/W2086892612","https://openalex.org/W2087657646","https://openalex.org/W2090931660","https://openalex.org/W2091939203","https://openalex.org/W2098580853","https://openalex.org/W2108634148","https://openalex.org/W2122836762","https://openalex.org/W2158776928","https://openalex.org/W2161645056","https://openalex.org/W2165398609","https://openalex.org/W2246813284","https://openalex.org/W2952201463","https://openalex.org/W4322696862"],"related_works":["https://openalex.org/W1966014889","https://openalex.org/W7010003128","https://openalex.org/W2112431572","https://openalex.org/W7027718315","https://openalex.org/W3019703117","https://openalex.org/W2259184309","https://openalex.org/W4404657234","https://openalex.org/W4292416265","https://openalex.org/W2550239319","https://openalex.org/W1970655997"],"abstract_inverted_index":{"Psychostimulant":[0],"addiction":[1,247],"is":[2,50,53],"a":[3,238],"chronically":[4],"relapsing":[5],"disorder":[6],"characterized":[7],"by":[8],"escalated":[9],"drug":[10,14],"intake":[11,187],"and":[12,69,141,159,173,185,211],"persistent":[13],"craving,":[15],"which":[16,102,198],"are":[17,225],"compulsive":[18,143,193,218],"behavioral":[19],"effects":[20,201],"due":[21],"to":[22,34,45,78,104,126,150,163],"negative":[23],"affective":[24],"states":[25],"experienced":[26],"during":[27],"withdrawal.":[28],"When":[29],"endogenous":[30],"opioid":[31],"dynorphin":[32],"binds":[33],"kappa-opioid":[35],"receptors":[36],"(KORs)":[37],"in":[38,120,192],"the":[39,46,59,63,72,90,94,118,134,142,156,200,217],"mesolimbic":[40,189],"system,":[41],"transmission":[42],"of":[43,58,66,86,89,107,128,153,176,202,209,213,230,244],"dopamine":[44],"nucleus":[47],"accumbens":[48],"(NAc)":[49],"decreased.":[51],"It":[52],"theorized":[54],"that":[55,216],"increased":[56,105,122],"activity":[57,106,124,140,191],"dynorphin/KOR":[60,91],"system":[61,92],"mediates":[62],"dysphoric":[64],"component":[65],"psychostimulant":[67,76],"withdrawal":[68],"thus":[70],"facilitates":[71],"transition":[73,95],"from":[74],"occasional":[75],"use":[77],"chronic":[79,222],"dependence.":[80,98],"This":[81],"thesis":[82,232],"examines":[83],"two":[84],"aspects":[85],"how":[87],"upregulation":[88],"drives":[93],"toward":[96],"methamphetamine":[97,177,186,223,246],"Dynorphin":[99],"activates":[100],"KORs,":[101],"leads":[103,125],"transcription":[108],"factor":[109],"cyclic":[110],"adenosine":[111],"monophosphate":[112],"response":[113],"element-binding":[114],"protein":[115],"(CREB)":[116],"within":[117,155],"NAc;":[119],"turn,":[121],"CREB":[123,139,190,236],"expression":[127],"more":[129],"dynorphin.":[130],"Experiment":[131,196],"1":[132],"explored":[133],"relationship":[135],"between":[136,182],"elevated":[137],"NAc":[138,157,183,235],"drug--taking":[144],"behavior":[145],"associated":[146,220],"with":[147,221],"extended":[148],"access":[149,164],"methamphetamine.":[151],"Immunoreactivity":[152],"phospho-CREB":[154,184],"core":[158],"shell":[160],"was":[161],"compared":[162],"condition":[165],"(1":[166],"h":[167,171],"limited-":[168],"or":[169],"6":[170],"extended-access)":[172],"overall":[174],"escalation":[175],"self-administration.":[178],"The":[179,227],"positive":[180],"correlation":[181],"implicates":[188],"methamphetamine-taking":[194],"behavior.":[195],"2,":[197],"examined":[199],"KOR":[203],"antagonist":[204],"nor-Binaltorphamine":[205],"(nor-BNI)":[206],"on":[207],"re-escalation":[208],"drug-taking":[210],"reinstatement":[212],"drug-seeking,":[214],"showed":[215],"behaviors":[219],"abuse":[224],"reversible.":[226],"combined":[228],"results":[229],"this":[231],"preliminarily":[233],"identify":[234],"as":[237],"potential":[239],"therapeutic":[240],"target":[241],"for":[242],"treatment":[243],"pre-existing":[245]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-08-23T00:00:00"}